Home › Leucemia mieloide acuta › Georgia › Augusta
Studi clinici su Leucemia mieloide acuta a Augusta, GA
10 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Augusta e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
In reclutamentoFase 2
- Augusta University Medical Center, Augusta
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Augusta University Medical Center, Augusta
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Augusta University Medical Center, Augusta
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Augusta University Medical Center, Augusta
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
In reclutamentoFase 3
- Augusta University Medical Center, Augusta
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
In reclutamentoFase 1
- Georgia Cancer Center at Augusta University, Augusta
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
In reclutamentoFase 2/3
- Augusta University - Georgia Cancer Center, Augusta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- Georgia Cancer Center at Augusta University Health, Augusta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
In reclutamentoFase 1
- Georgia Cancer Center at Augusta University, Augusta
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
In reclutamentoFase 2
- Georgia Cancer Center at Augusta University, Augusta
Studi su Leucemia mieloide acuta in altre città
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Baldwin Park, CA40 studi
- Seattle, WA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA30 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Altri studi a Augusta
- Cancro ovarico8 studi
- Cancro dell'endometrio7 studi
- Cancro (tutti i tipi)7 studi
- Anemia falciforme5 studi
- Cancro al seno5 studi
- Miastenia grave4 studi
- Neoplasie del sangue4 studi
- Linfoma di Burkitt4 studi
- Linfoma diffuso a grandi cellule B4 studi
- Leucemia mieloide cronica4 studi
- Linfoma non Hodgkin4 studi
- Cancro della cervice uterina4 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.